Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Paracetamol vs Metoclopramide on Postoperative Nausea and Vomiting

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
Hali
Wadhamini
Aydin Adnan Menderes University

Maneno muhimu

Kikemikali

The drugs with both high potency and low side effects are preferred in the prevention of postoperative nausea and vomiting (PONV) which is a common problem. This prospective randomized study aimed to compare the efficacy of paracetamol and metoclopramide on PONV in adults undergoing maxillofacial surgery.

Maelezo

One hundred-twenty patients are randomly divided into two groups; the paracetamol group who received the IV infusion of paracetamol (1.5 ml/kg); and the metoclopramide group who received the IV infusion of metoclopramide (0.2 mg/kg) in saline. The presence of vomiting and the actions indicative of nausea, such as repeated gagging or spitting, within 24h following general anesthesia are defined as PONV. All PONV episodes and postoperative pain scores are recorded during 24h postoperatively. The postoperative 0-4h and 4-24h are defined as early and late postoperative period, respectively. Intravenous 4 mg ondansetron as rescue antiemetic drug is administered in case of two or more vomiting episodes.

Tarehe

Imethibitishwa Mwisho: 06/30/2018
Iliyowasilishwa Kwanza: 07/04/2018
Uandikishaji uliokadiriwa Uliwasilishwa: 07/04/2018
Iliyotumwa Kwanza: 07/16/2018
Sasisho la Mwisho Liliwasilishwa: 07/04/2018
Sasisho la Mwisho Lilichapishwa: 07/16/2018
Tarehe halisi ya kuanza kwa masomo: 07/19/2018
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 08/19/2018
Tarehe ya Kukamilisha Utafiti: 08/20/2018

Hali au ugonjwa

Postoperative Nausea and Vomiting

Uingiliaji / matibabu

Drug: Perfalgan

Drug: Metoclopramide

Awamu

Awamu 4

Vikundi vya Arm

MkonoUingiliaji / matibabu
Active Comparator: Perfalgan
1.5 mg/kg intravenous, intraoperative (20 min before end of the surgery)
Active Comparator: Metoclopramide
0.2 mg/kg intravenous, intraoperative (20 min before end of the surgery)

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- ASA (the classification of the American Society of Anesthesiologists) physical status I-II

- Patients who scheduled for elective maxillofacial surgery under general anesthesia

Exclusion Criteria:

- Patients with a history of allergy to any of the study medications (opioid, general anesthetic agents or paracetamol)

- History of opioid use, hepatic or renal disease, coronary, psychotic and neurologic diseases

- Use of antiemetic, antihistaminic, analgesic or corticosteroid 24 hours (h) prior to surgery

Matokeo

Hatua za Matokeo ya Msingi

1. Preventing of postoperative nausea and vomiting [First 24 hours postoperatively]

Preventing of postoperative nausea and vomiting in postoperative care unit

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge